claim

SELECTED PUBLICATIONS
Nicolas Thomä


Fischer ES, Böhm K, Lydeard JR, Yang H, Stadler MB, Cavadini S, Nagel J, Serluca F, Acker V, Lingaraju GM, Tichkule RB, Schebesta M, Forrester WC, Schirle M, Hassiepen U, Ottl J, Hild M, Beckwith RE, Harper JW, Jenkins JL, Thomä NH (2014) Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.
Nature 512:49-53

Lingaraju GM, Bunker RD, Cavadini S, Hess D, Hassiepen U, Renatus M, Fischer ES, Thomä NH (2014) Crystal structure of the human COP9 signalosome.
Nature. 2014 Jul 16. doi: 10.1038/nature13566. [Epub ahead of print]

Bocquet N, Bizard AH, Abdulrahman W, Larsen NB, Faty M, Cavadini S, Bunker RD, Kowalczykowski SC, Cejka P, Hickson ID, Thomä NH (2014) Structural and mechanistic insight into Holliday-junction dissolution by topoisomerase IIIa and RMI1.
Nat Struct Mol Biol. 21:261-8

Shi T, Bunker RD, Mattarocci S, Ribeyre C, Faty M, Gut H, Scrima A, Rass U, Rubin SM, Shore D, Thomä NH (2013) Rif1 and Rif2 shape telomere function and architecture through multivalent Rap1 interactions.
Cell 153:1340-53

Fischer ES, Scrima A, Böhm K, Matsumoto S, Lingaraju GM, Faty M, Yasuda T, Cavadini S, Wakasugi M, Hanaoka F, Iwai S, Gut H, Sugasawa K, Thomä NH (2011) The molecular basis of CRL4(DDB2/CSA) ubiquitin ligase architecture, targeting and release of signalosome inhibition.
Cell, 147, 5, 1024-1039

Schmitges FW, Prusty AB, Faty M, Stützer A, Lingaraju GM, Aiwazian J, Sack R, Hess D, Li L, Zhou S, Bunker RD, Wirth U, Bouwmeester T, Bauer A, Ly-Hartig N, Zhao K, Chan H, Gu J, Gut H, Fischle W, Müller J, Thomä NH (2011) Histone methylation by PRC2 is inhibited by active chromatin marks.
Mol Cell 42:330-41.

Scrima A, Konickova R, Czyzewski B, Kawasaki Y, Jeffrey P, Groisman R, Nakatani Y, Iwai S, Pavletich N, Thomä N (2008) Structural basis of UV DNA-damage recognition by the DDB1-DDB2 complex.
Cell 135:1213-1223

Full list of publications
» Search with Medline
About this site2018 © FMI Basel Switzerland